REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Gan & Lee Pharmaceuticals. (甘李药业股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Gan & Lee Pharmaceuticals. Profile Updated: March 01, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Gan & Lee Pharmaceuticals is a pharmaceutical company that specializes in the development of genetic reorganizer inzulin technology and supports clinical endocrine metabolic diseases.

Headquarters
No. 8, Nanfeng West 1st Road, Miao County, Tongzhou District, Beijing
Beijing; Beijing; Postal Code: 101102

Contact Details: Purchase the Gan & Lee Pharmaceuticals. (甘李药业股份有限公司) report to view the information.

Website: http://www.ganlee.com.cn

Basic Information
Total Employees:
Purchase the Gan & Lee Pharmaceuticals. (甘李药业股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Gan & Lee Pharmaceuticals. (甘李药业股份有限公司) report to view the information.
Registered Capital:
Purchase the Gan & Lee Pharmaceuticals. (甘李药业股份有限公司) report to view the information.
Financial Auditors:
Purchase the Gan & Lee Pharmaceuticals. (甘李药业股份有限公司) report to view the information.
Incorporation Date:
June 17, 1998
Key Executives
Purchase this report to view the information.
Supervisor
Purchase this report to view the information.
Supervisor
Ownership Details
Purchase this report to view the information.
34.61%
Purchase this report to view the information.
8.15%
Purchase this report to view the information.
7.99%
Purchase this report to view the information.
5.41%
Purchase this report to view the information.
1.05%
Subsidiaries
Beijing Dingye Haoda Technology Co., Ltd.
100%
Beijing Gangan Technology Co., Ltd.
100%
G&L HOLDINGS NEW JERSEY INC
100%
Company Performance
Financial values in the chart are available after Gan & Lee Pharmaceuticals. (甘李药业股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
35.73%▲
Total operating revenue
26.78%▲
Operating Profit/Loss (EBIT)
54.49%▲
Net Profit/Loss for the Period
61.32%▲
Total Assets
-0.65%▼
Total Equity
0.67%▲
Operating Profit Margin (ROS)
3.47%▲
Net Profit Margin
4.26%▲
Return on Equity (ROE)
2.72%▲
Quick Ratio
-1.2%▼
Cash Ratio
-1.35%▼

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
JD Health International Inc.
Nanjing Pharmaceutical Company Limited
 
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (上海复星医药(集团)股份有限公司)
Xiamen Kingdomway Group Company
 
Tianjin Tianyao Pharmaceuticals Co.,Ltd
Guangzhou Wondfo Biotech Co.,Ltd
 
Tianjin Ringpu Bio-Technology Co.,Ltd.
Porton Pharma Solutions Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo